Team:USTC CHINA/Project/ProjectDetails/Background
From 2013.igem.org
(Difference between revisions)
Line 78: | Line 78: | ||
<img src="https://static.igem.org/mediawiki/2013/9/97/%E9%80%8F%E7%9A%AE%E8%82%BD%E5%BA%8F%E5%88%97.png" /> | <img src="https://static.igem.org/mediawiki/2013/9/97/%E9%80%8F%E7%9A%AE%E8%82%BD%E5%BA%8F%E5%88%97.png" /> | ||
Title of Nature Letter About TD1<br> | Title of Nature Letter About TD1<br> | ||
- | <img src="https://static.igem.org/mediawiki/2013/a/a7/Nature.png" width="580" height=" | + | <img src="https://static.igem.org/mediawiki/2013/a/a7/Nature.png" width="580" height="400" /> |
<h3>2. the Principle of TD1:<h3> | <h3>2. the Principle of TD1:<h3> | ||
<p>The biggest challenge of penetrating the skin is epidermis of skin barrier. Traditional transdermal methods have to break the epidermis, though it maybe painless, the injury still have the potential of infection. On the contrary, TD1 is painless and harmless to skin, it could open the skin channels shortly, so not only molecules but also filobactivirus could penetrate the skin and go into the blood circulation system.<p> | <p>The biggest challenge of penetrating the skin is epidermis of skin barrier. Traditional transdermal methods have to break the epidermis, though it maybe painless, the injury still have the potential of infection. On the contrary, TD1 is painless and harmless to skin, it could open the skin channels shortly, so not only molecules but also filobactivirus could penetrate the skin and go into the blood circulation system.<p> |
Revision as of 10:17, 27 September 2013